Portola Pharmaceuticals, Inc. engages in the development and commercialization of novel therapeutics in the areas of thrombosis, other hematologic disorders, and inflammation. It offers Andexxa and Bevyxxa medicines. The company was founded by Charles J. Homcy and David R. Philips on September 2, 2003 and is headquartered in South San Francisco, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Other
Employees:
408
Frequently Asked Questions
What is Market Cap of Portola Pharmaceuticals Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Portola Pharmaceuticals Inc market cap is $1.42B.
What is the 52-week high for Portola Pharmaceuticals Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Portola Pharmaceuticals Inc 52 week high is $31.73 as of September 08, 2025.
What is the 52-week low for Portola Pharmaceuticals Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Portola Pharmaceuticals Inc 52 week low is $5.31 as of September 08, 2025.
What is Portola Pharmaceuticals Inc stock price today?
Portola Pharmaceuticals Inc stock price today is $18.03.
What was Portola Pharmaceuticals Inc stock price yesterday?
Portola Pharmaceuticals Inc stock price yesterday was $17.99.
What is the PE ratio of Portola Pharmaceuticals Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Portola Pharmaceuticals Inc’s P/E ratio is None.
What is the Price-to-Book ratio of Portola Pharmaceuticals Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Portola Pharmaceuticals Inc P/B ratio is 19.6448.
What is Portola Pharmaceuticals Inc's EBITDA?
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Portola Pharmaceuticals Inc's EBITDA is -2.22.
What is the 50-day moving average of Portola Pharmaceuticals Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Portola Pharmaceuticals Inc 50-day moving average is $16.20.
How many employess does Portola Pharmaceuticals Inc has?
